Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathways to a robust immune response in the elderly.

Graham Pawelec1, Qin Ouyang, Wolfgang Wagner

  • 1Second Department of Internal Medicine, University of Tübingen Medical School, Waldhörnlestr. 22, D-72076 Tübingen, Germany. graham.pawelec@uni-tuebingen.de

Immunology and Allergy Clinics of North America
|March 21, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune aging biomarkers for clinical trials.

Nature medicine·2026
Same author

Comparing fourteen consensus biomarkers of aging: epigenetic pace of aging as the strongest predictor of mortality in BASE-II.

Biomarker research·2026
Same author

Vδ1 T-cell subset appears to be responsive to PD-1 blockade therapy and is associated with survival in melanoma.

Journal for immunotherapy of cancer·2026
Same author

Aging-associated immune signature as a predictor of mortality in end-stage renal disease: results from the longitudinal iESRD study.

Immunity & ageing : I & A·2025
Same author

Open problems in ageing science: a roadmap for biogerontology.

GeroScience·2025
Same author

Clinical data-driven classification of pre-frailty reveals sex-specific patterns - Data from the Berlin Aging Study II (BASE-II).

Mechanisms of ageing and development·2025

Aging T cells are linked to mortality in the elderly. Identifying immune risk profiles (IRP) and biomarkers could improve health and reduce healthcare costs.

Area of Science:

  • Immunology
  • Gerontology

Background:

  • Infectious diseases cause significant morbidity and mortality in the elderly, potentially linked to immune dysfunction.
  • While innate and humoral immunity remain largely unaffected by aging, T-cell compartments exhibit significant age-associated alterations.

Purpose of the Study:

  • To investigate the association between T cells and aging.
  • To identify immune parameters predictive of mortality in the elderly.
  • To explore biomarkers for immune aging.

Main Methods:

  • Analysis of longitudinal studies focusing on T-cell related immune parameters.
  • Clustering of immune parameters to define an Immune Risk Profile (IRP).
  • In vitro modeling of T-cell changes to identify biomarkers.

Related Experiment Videos

Main Results:

  • Immune parameters, predominantly T-cell related, can be clustered into an IRP.
  • The IRP is predictive of mortality in the elderly.
  • Potential biomarkers for immune aging can be identified through in vitro T-cell studies.

Conclusions:

  • The IRP, derived from T-cell parameters, can predict mortality in the elderly.
  • IRP determination may also benefit younger individuals under chronic antigenic stress.
  • Targeted interventions based on IRP and biomarkers could enhance health and reduce healthcare costs in the elderly.